The age‑related vision dysfunction drugs market is expanding due to rising prevalence of age-related macular degeneration, dry eye syndrome, and cataracts in aging populations, driving demand for anti-VEGF therapies, neuroprotective agents, and ocular supplements. https://www.datamintelligence.com/research-report/age-related-vision-dysfunction-drugs-market